NLA researchers to win National Competition on Innovations 18.10.2018 The initiative scientific research results of NLA researchers from the Laboratory of Bioengineering and Regenerative Medicine was recognized as one of the most innovative by the results of the 2018 National Competition of Innovations and the rating of innovative companies.
The cash prize as the second place holders in the amount of 800 thousand tenge was ...
INESS-2018 to be held in NU 03.08.2018 We are glad to announce the 6th International Conference on Nanomaterials and Advanced Energy Storage Systems (INESS-2018) joint with the 10th International Symposium on Inorganic Phosphate Materials 2018 (ISIPM-10),organized by Nazarbayev University (NU), Institute of Batteries (IoB), National Laboratory Astana (NLA) and Japanese Association of Inorganic Phosphorus Chemistry to be held on August 8-10, 2018 in ...
Gene Therapy for Cancer 20.06.2018 On June 12-13, 2018 researchers of National Laboratory Astana with the support of “ALBIOGEN” company (Moscow, Russia) gave lectures and practical sessions within the framework of “Targeted DNA sequencing from tumor tissues. AmpliSeq ™ for Illumina Cancer Hotspot Panel v2” seminar.
Groups of employees of the Kazakh Scientific Research Institute of Oncology and Radiology (Almaty), and ...
“NӘR” synbiotic to put into production in Astana 25.04.2018 Today, the first batches of “NӘR” functional food product were produced in a package with an improved design at the milk factory of “Agrofirma Rodina” LLP.It is known that the synbiotic “NӘR” is the first functional food product created by NLA researchers, which has a number of unique properties, including increases immunity and promotes active longevity. ...
NU researchers to create electric wheelchairs 24.04.2018 Today, Institute of Batteries, NU and NLA researchers delivered electric wheelchairs designed to disabled people. Four citizens of Astana were awarded these electrical drives. This project was realized in conjunction and sponsorship of Institute of Batteries, “Zhan Dosym” Fund and Kazyna Capital Management.
